Frontiers in Pharmacology (Jun 2022)
The Potential Use of Antibiotics Against Helicobacter pylori Infection: Biopharmaceutical Implications
- Amir Hossein Miri,
- Amir Hossein Miri,
- Mojtaba Kamankesh,
- Antoni Llopis-Lorente,
- Chenguang Liu,
- Matthias G. Wacker,
- Ismaeil Haririan,
- Hamid Asadzadeh Aghdaei,
- Michael R. Hamblin,
- Abbas Yadegar,
- Mazda Rad-Malekshahi,
- Mohammad Reza Zali
Affiliations
- Amir Hossein Miri
- Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
- Amir Hossein Miri
- Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Mojtaba Kamankesh
- Polymer Chemistry Department, School of Science, University of Tehran, Tehran, Iran
- Antoni Llopis-Lorente
- Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, Netherlands
- Chenguang Liu
- College of Marine Life Science, Ocean University of China, Qingdao, China
- Matthias G. Wacker
- Department of Pharmacy, National University of Singapore, Singapore, Singapore
- Ismaeil Haririan
- Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
- Hamid Asadzadeh Aghdaei
- Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Michael R. Hamblin
- Laser Research Centre, Faculty of Health Science, University of Johannesburg, Doornfontein, South Africa
- Abbas Yadegar
- Foodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Mazda Rad-Malekshahi
- Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
- Mohammad Reza Zali
- Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- DOI
- https://doi.org/10.3389/fphar.2022.917184
- Journal volume & issue
-
Vol. 13
Abstract
Graphical Abstract
Keywords
- H. pylori
- antibiotic therapy
- biopharmaceutical principles
- pharmaceutical microbiology
- pharmacokinetics
- pharmacodynamics